COMMUNIQUÉS West-GlobeNewswire

TScan Therapeutics Announces Closing of Upsized Public Offering

19/04/2024 - 16:05

WALTHAM, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR [...]

ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure

19/04/2024 - 15:00

Study will enroll participants who initiated treatment shortly after acquiring HIV LOS ANGELES, April 19, 2024 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, [...]

PharmAla Closes Private Placement and Concurrent Debt Settlement

19/04/2024 - 14:35

VANCOUVER, British Columbia, April 19, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, [...]

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

19/04/2024 - 14:30

Experienced healthcare and rehabilitation technology professional brings more than 30 years of experience in commercialization and new business development MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 19, 2024 ( [...]

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

19/04/2024 - 14:30

BERKELEY HEIGHTS, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and [...]

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023

19/04/2024 - 14:10

The Company Concluded the Year With Revenue Doubling, Alongside Substantial Improvements in Gross Profit Margins and Net Income FORT LAUDERDALE, FL, April 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – VPR Brands LP ( [...]

3Daughters Named “Startup of the Year” at BioLabs Philadelphia Investor Day 2024

19/04/2024 - 14:00

MANSFIELD, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- 3Daughters , Inc., a clinical development company fueling evolutionary healthcare for women, was voted the “Startup of Year” by top life science investors and venture [...]

NeuroMetrix Announces Steps Taken to Enhance Shareholder Value

19/04/2024 - 14:00

Joshua S. Horowitz joins Board of Directors At-the-market equity facility terminated WOBURN, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced two steps to enhance shareholder [...]

Preliminary Results for the Year Ended 31 December 2023

19/04/2024 - 14:00

19 April 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Preliminary Results for the Year Ended 31 December 2023 Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), [...]

Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy

19/04/2024 - 13:13

MALVERN, Pa., April 19, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and [...]

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®

19/04/2024 - 13:00

- Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) - - Data presented in a platform session at the [...]

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

19/04/2024 - 13:00

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced [...]

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)

19/04/2024 - 12:10

Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar to Humira® The [...]

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)

19/04/2024 - 12:10

Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar to Humira ® The [...]

Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award

19/04/2024 - 12:00

WASHINGTON, April 19, 2024 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award [...]

Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer

19/04/2024 - 10:08

Leiden, The Netherlands, 19 April 2024 – Amarna Therapeutics , a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, including Type 1 Diabetes [...]

FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer

19/04/2024 - 07:00

Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage resected non-small cell lung cancer (NSCLC) 1 This [...]

Addex to Present at the Swiss Biotech Day 2024

19/04/2024 - 07:00

Geneva, Switzerland, April 19, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will [...]

2024 Helen Keller Achievement Awards Ceremony Celebrates Media Inclusion

19/04/2024 - 04:45

Filmmaker Shawn Levy and Actor Marilee Talkington Honored as Trailblazers for Inclusion Lucasfilm Lauded as Leader in Accessible Entertainment LOS ANGELES, April 18, 2024 (GLOBE NEWSWIRE) -- The American Foundation for [...]